Why Agilent Technologies Just Paid $950 Million For Biocare Medical (NYSE:A)

Agilent Technologies, Inc. ( A ) has just announced the acquisition of Biocare Medical. And while the stock price hasn't reacted that much, I feel Biocare's current portfolio should come as a big help in termsI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the ri ...